Literature DB >> 8675259

Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy.

P M Okin1, M J Roman, R B Devereux, P Kligfield.   

Abstract

Patients with carotid atherosclerosis have an increased risk of coronary events and an increased prevalence of echocardiographic left ventricular hypertrophy. However, little is known regarding the association between electrocardiographic abnormalities and carotid atherosclerosis. The relationship of electrocardiographic evidence of myocardial ischemia and left ventricular hypertrophy to the presence of carotid atherosclerosis was prospectively studied in 349 asymptomatic subjects who underwent echocardiography and carotid ultrasonography. Myocardial ischemia on the electrocardiogram was defined by the presence of localized T-wave inversions, and electrocardiographic hypertrophy was defined by the product of Cornell voltage and QRS duration. Carotid atherosclerosis was present in 21% (72/ 349) of subjects and was associated with older age, higher systolic and pulse pressures, and greater left ventricular mass. Both ischemia and hypertrophy on the electrocardiogram were strongly associated with carotid plaque. Carotid atherosclerosis was more than three times more prevalent in subjects with electrocardiographic ischemia (69% [11/16] versus 18% [61/333], P < .0001) or electrocardiographic left ventricular hypertrophy (78% [7/9] versus 19% [65/340], P = .0003) than in subjects without these findings. Logistic regression analysis, including standard risk factors, revealed that both ischemia and hypertrophy on the electrocardiogram remained significant independent predictors of the presence of carotid atherosclerosis, along with age and echocardiographic left ventricular mass. These findings suggest that the associations of ischemia and left ventricular hypertrophy with carotid atherosclerosis may contribute to the increased incidence of coronary events in patients with carotid atherosclerosis.

Entities:  

Mesh:

Year:  1996        PMID: 8675259     DOI: 10.1161/01.hyp.28.1.3

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.

Authors:  T J Smilde; M D Trip; H Wollersheim; S van Wissen; J J Kastelein; A F Stalenhoef
Journal:  Clin Drug Investig       Date:  2000       Impact factor: 2.859

2.  Left ventricular mass and geometry and the risk of ischemic stroke.

Authors:  Marco R Di Tullio; Donna R Zwas; Ralph L Sacco; Robert R Sciacca; Shunichi Homma
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914

3.  Carotid Atherosclerosis and Electrocardiographic Left Ventricular Hypertrophy in the General Population: The Namwon Study.

Authors:  Nam-Ho Kim; Min-Ho Shin; Sun-Seog Kweon; Jum Suk Ko; Young-Hoon Lee
Journal:  Chonnam Med J       Date:  2017-05-25

4.  Short-term outcomes after hospital discharge in patients admitted with heart failure in Abeokuta, Nigeria: data from the Abeokuta Heart Failure Registry.

Authors:  Okechukwu S Ogah; Simon Stewart; Ayodele O Falase; Joshua O Akinyemi; Gali D Adegbite; Albert A Alabi; Amina Durodola; Akinlolu A Ajani; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2014-09-10       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.